Earnings History Data for Monopar Therapeutics Inc. (MNPR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Monopar Therapeutics Inc.

Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-11-2021 PM MNPR Monopar Therapeutics Inc. 53.25 -0.20 -0.22 -0.27 Monopar Therapeutics EPS beats by $0.01
[11/12/2021 8:12 AM]
5.00 -0.01 
(-0.20%)
5.18 0.17 
(3.39%)
4.50 - 17.01 21,743 60,000 728
13-05-2021 AH After the close
(May 13)
MNPR Monopar Therapeutics Inc. 54.76 -0.16 -0.22 -0.10 Monopar Therapeutics EPS beats by $0.04
[5/13/2021 5:23 PM]
5.22 0.17 
(3.37%)
5.25 0.09 
(1.74%)
4.28 - 17.01 13,542 20,000 250
25-03-2021 PM MNPR Monopar Therapeutics Inc. 77.00 -0.19 -0.15 0.00 Monopar Therapeutics EPS misses by $0.01
[3/25/2021 9:03 AM]
6.28 -0.44 
(-6.55%)
6.80 0.08 
(1.19%)
4.28 - 17.01 85,434 40,000 530
12-11-2020 PM MNPR Monopar Therapeutics Inc. 46.81 -0.27 -0.15 0.00 Monopar Therapeutics EPS beats by $0.02
[11/12/2020 9:22 AM]
4.90 0.22 
(4.70%)
5.00 0.32 
(6.84%)
4.28 - 48.00 60,767 16,664 300